发明名称 USES OF MONOCLONAL ANTIBODY 8H9
摘要 <p>This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof.</p>
申请公布号 WO0232375(A2) 申请公布日期 2002.04.25
申请号 WO2001US32565 申请日期 2001.10.18
申请人 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH;CHEUNG, NAI-KONG, V. 发明人 CHEUNG, NAI-KONG, V.
分类号 A61K47/48;A61K49/00;A61P43/00;C07K16/00;C07K16/18;C07K16/30;C07K16/42;(IPC1-7):A61K/ 主分类号 A61K47/48
代理机构 代理人
主权项
地址